Additional evidences indicate that accumulation of TAMs and MDSCs in tumor tissues, as well as in metastasis, is guided by specific chemotactic pathways (eg. CCL2, M-CSF, CXCL2) [3, 28], suggesting possible therapeutic strategies to limit their recruitment and contribution to tumor growth. The gene discussed is CCL2; the disease is neoplasm.